North America retains the largest revenue shareโjust under 42% in 2025โthanks to high ASPs, entrenched outpatient surgical networks, and favorable reimbursement for lipedema cases. Asia-Pacific, however, is the fastest-expanding region (โ8% CAGR), underpinned by medical-tourism hubs in Thailand, India, and South Korea that bundle energy-assisted lipo at 40โ60% discounts to U.S. list prices. Competitive intensity is ratcheting higher as Tier-1 players (e.g., Solta, Candela, Mentor) vertically integrate disposable cannula manufacturing to protect margins, while Chinese OEMs flood the mid-tier with portable, console-free aspirators priced below US$ 7k. Supply-chain volatilityโparticularly medical-grade silicone tubing lead timesโremains the key wildcard, prompting vendors to dual-source polymers and carry 9โ12-month safety stock.